Tractography of the Brainstem in Major Depressive Disorder Using Diffusion Tensor Imaging

Background The brainstem is the main region that innervates neurotransmitter release to the Hypothalamic-Pituitary Adrenal (HPA) axis and fronto-limbic circuits, two key brain circuits found to be dysfunctional in Major Depressive Disorder (MDD). However, the brainstem’s role in MDD has only been evaluated in limited reports. Using Diffusion Tensor Imaging (DTI), we investigated whether major brainstem white matter tracts that relate to these two circuits differ in MDD patients compared to healthy controls. Methods MDD patients (n = 95) and age- and gender-matched controls (n = 34) were assessed using probabilistic tractography of DTI to delineate three distinct brainstem tracts: the nigrostriatal tract (connecting brainstem to striatum), solitary tract (connecting brainstem to amygdala) and corticospinal tract (connecting brainstem to precentral cortex). Fractional anisotropy (FA) was used to measure the white matter integrity of these tracts, and measures were compared between MDD and control participants. Results MDD participants were characterized by a significant and specific decrease in white matter integrity of the right solitary tract (p<0.009 using independent t-test), which is a “bottom up” afferent pathway that connects the brainstem to the amygdala. This decrease was not related to symptom severity. Conclusions The results provide new evidence to suggest that structural connectivity between the brainstem and the amygdala is altered in MDD. These results are interesting in light of predominant theories regarding amygdala-mediated emotional reactivity observed in functional imaging studies of MDD. The characterization of altered white matter integrity in the solitary tract in MDD supports the possibility of dysfunctional brainstem-amygdala connectivity impacting vulnerable circuits in MDD.

[1]  S. Wisniewski,et al.  Brain imaging predictors and the international study to predict optimized treatment for depression: study protocol for a randomized controlled trial , 2013, Trials.

[2]  P. Blier,et al.  Serotonin and beyond: therapeutics for major depression , 2013, Philosophical Transactions of the Royal Society B: Biological Sciences.

[3]  A. Rush,et al.  A patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for treatment-resistant depression , 2013, Medical devices.

[4]  D. Schutter.  The cerebello-hypothalamic-pituitary-adrenal axis dysregulation hypothesis in depressive disorder. , 2012, Medical hypotheses.

[5]  Guillén Fernández,et al.  Fronto-limbic microstructure and structural connectivity in remission from major depression , 2012, Psychiatry Research: Neuroimaging.

[6]  Julia C. Lemos,et al.  Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive , 2012, Nature.

[7]  Leanne M. Williams,et al.  Mapping inter-regional connectivity of the entire cortex to characterize major depressive disorder: a whole-brain diffusion tensor imaging tractography study , 2012, Neuroreport.

[8]  J. Gabrieli,et al.  Loss of white matter integrity in major depressive disorder: Evidence using tract‐based spatial statistical analysis of diffusion tensor imaging , 2011, Human brain mapping.

[9]  Byung-Joo Ham,et al.  Demonstration of decreased gray matter concentration in the midbrain encompassing the dorsal raphe nucleus and the limbic subcortical regions in major depressive disorder: an optimized voxel-based morphometry study. , 2011, Journal of affective disorders.

[10]  M. Mallar Chakravarty,et al.  Longitudinal MR study of brain structure and hippocampus volume in major depressive disorder , 2011, Acta psychiatrica Scandinavica.

[11]  Jesús Pujol,et al.  Cross-Sectional and Longitudinal Assessment of Structural Brain Alterations in Melancholic Depression , 2011, Biological Psychiatry.

[12]  S. Wisniewski,et al.  International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol , 2011, Trials.

[13]  Bruce R. Rosen,et al.  Microstructural Abnormalities in Subcortical Reward Circuitry of Subjects with Major Depressive Disorder , 2010, PloS one.

[14]  R. Kahn,et al.  Aberrant Frontal and Temporal Complex Network Structure in Schizophrenia: A Graph Theoretical Analysis , 2010, The Journal of Neuroscience.

[15]  Erno J. Hermans,et al.  Enhanced resting-state connectivity of amygdala in the immediate aftermath of acute psychological stress , 2010, NeuroImage.

[16]  Osamu Abe,et al.  Voxel-based analyses of gray/white matter volume and diffusion tensor data in major depression , 2010, Psychiatry Research: Neuroimaging.

[17]  J. Kornhuber,et al.  Cardiac Effects of Vagus Nerve Stimulation in Patients with Major Depression , 2009, Pharmacopsychiatry.

[18]  M. Fukuda,et al.  HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions , 2007, Psychiatry Research: Neuroimaging.

[19]  Igor Malinovsky,et al.  Preliminary Results of an Open Label Study of Heart Rate Variability Biofeedback for the Treatment of Major Depression , 2007, Applied psychophysiology and biofeedback.

[20]  G. Glover,et al.  Dissociable Intrinsic Connectivity Networks for Salience Processing and Executive Control , 2007, The Journal of Neuroscience.

[21]  Mark W. Woolrich,et al.  Probabilistic diffusion tractography with multiple fibre orientations: What can we gain? , 2007, NeuroImage.

[22]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[23]  Alan Frazer,et al.  VNS Therapy in Treatment-Resistant Depression: Clinical Evidence and Putative Neurobiological Mechanisms , 2006, Neuropsychopharmacology.

[24]  S. Watson,et al.  HPA axis function in mood disorders , 2006 .

[25]  W. Maier,et al.  Changes in regional cerebral blood flow by therapeutic vagus nerve stimulation in depression: An exploratory approach , 2005, Psychiatry Research: Neuroimaging.

[26]  J. Tsien,et al.  Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Valentino,et al.  A Neurochemically Distinct Dorsal Raphe-Limbic Circuit with a Potential Role in Affective Disorders , 2003, Neuropsychopharmacology.

[28]  J. Patterson,et al.  Investigation into the mechanisms of vagus nerve stimulation for the treatment of intractable epilepsy, using 99mTc-HMPAO SPET brain images , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  R. Valentino,et al.  Corticotropin‐Releasing Factor Neurones of the Central Nucleus of the Amygdala Mediate Locus Coeruleus Activation by Cardiovascular Stress , 2002, Journal of neuroendocrinology.

[30]  Marcus E Raichle,et al.  Glucose metabolism in the amygdala in depression: Relationship to diagnostic subtype and plasma cortisol levels , 2002, Pharmacology Biochemistry and Behavior.

[31]  A. Loewy,et al.  Synaptic and Neurotransmitter Activation of Cardiac Vagal Neurons in the Nucleus Ambiguus , 2001, Annals of the New York Academy of Sciences.

[32]  S. Krahl,et al.  Locus Coeruleus Lesions Suppress the Seizure‐Attenuating Effects of Vagus Nerve Stimulation , 1998, Epilepsia.

[33]  R. Dolan,et al.  Conscious and unconscious emotional learning in the human amygdala , 1998, Nature.

[34]  M. Morimoto,et al.  Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: an immunohistochemical and in situ hybridization study , 1996, Neuroscience Research.

[35]  T. Gray,et al.  Amygdaloid CRF Pathways: Role in Autonomic, Neuroendocrine, and Behavioral Responses to Stress , 1993, Annals of the New York Academy of Sciences.

[36]  K. Krishnan,et al.  Posterior fossa abnormalities in major depression: a controlled magnetic resonance imaging study , 1992, Acta psychiatrica Scandinavica.